open access
TeleNEN as a telemedicine model for neuroendocrine neoplasm management in case of Meckel’s diverticulum NET


- Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland
- Department of Endocrinology and Neuroendocrine Tumors, Medical University of Silesia, Katowice, Poland
- Chair and Department of General, Gastroenterological and Oncological Surgery, Medical University of Warsaw, Warsaw, Poland
- Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland
- Chair and Department of Nuclear Medicine, Medical University of Lublin, Lublin, Poland
- Division of Endocrinology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
open access
Abstract
Abstract
Keywords
Meckel neuroendocrine tumour, 68Ga-DOTATATE, 99mTc-HYNICTOC, 90Y/177Lu-DOTATATE, tandem PRRT


Title
TeleNEN as a telemedicine model for neuroendocrine neoplasm management in case of Meckel’s diverticulum NET
Journal
Issue
Article type
Case report
Pages
313-317
Published online
2018-06-25
Page views
2427
Article views/downloads
1072
DOI
10.5603/EP.2018.0033
Pubmed
Bibliographic record
Endokrynol Pol 2018;69(3):313-317.
Keywords
Meckel neuroendocrine tumour
68Ga-DOTATATE
99mTc-HYNICTOC
90Y/177Lu-DOTATATE
tandem PRRT
Authors
Jolanta Kunikowska
Anna Zemczak
Monika Górska
Renata Matyskiel
Maciej Słodkowski
Izabela Łoń
Beata Chrapko
Beata Kos-Kudła
Leszek Królicki


- Tomassetti P. Clinical aspects of carcinoid tumours. Ital J Gastroenterol Hepatol. 1999; 31 Suppl 2: S143–S146.
- Dejong CHC, Parks RW, Currie E, et al. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience. J R Coll Surg Edinb. 2002; 47(2): 495–499.
- Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97(4): 934–959.
- Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007; 48(4): 508–518.
- Srirajaskanthan R, Kayani I, Quigley AM, et al. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med. 2010; 51(6): 875–882.
- Artiko V, Afgan A, Petrović J, et al. Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC. Nucl Med Rev Cent East Eur. 2016; 19(2): 99–103.
- Kunikowska J, Lewington V, Krolicki L. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management. Clin Nucl Med. 2017; 42(12): 905–911.
- Deppen SA, Blume J, Bobbey AJ, et al. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J Nucl Med. 2016; 57(6): 872–878.
- Kaemmerer D, Prasad V, Daffner W, et al. Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: a pilot study. Clin Nucl Med. 2012; 37(2): 142–147.
- Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, et al. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2017; 68(2): 79–110.
- Kunikowska J, Pawlak D, Bąk MI, et al. Long-term results and tolerability of tandem peptide receptor radionuclide therapy with Y/Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study. Ann Nucl Med. 2017; 31(5): 347–356.
- Selverstone B, Solomon AK, Sweet WH. Location of brain tumors by means of radioactive phosphorus. J Am Med Assoc. 1949; 140(3): 277.
- Sadowski SM, Millo C, Neychev V, et al. Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2015; 22 Suppl 3: S676–S682.
- Kunikowska J, Słodkowski M, Koperski Ł, et al. Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation — case report. Nucl Med Rev Cent East Eur. 2014; 17(2): 110–114.